Jordi Vila Selected Research

Jordi Vila Research Topics

Disease

44	Infections 07/2022 - 04/2002
11	Pneumonia (Pneumonitis) 01/2021 - 04/2006
10	Diarrhea 01/2019 - 10/2004
8	COVID-19 06/2022 - 01/2021
8	Sepsis (Septicemia) 11/2019 - 03/2011
5	Cross Infection (Nosocomial Infection) 01/2020 - 09/2009
5	Pyelonephritis 08/2015 - 10/2002
4	Fibrosis (Cirrhosis) 01/2022 - 01/2002
4	Bacteremia 09/2020 - 03/2011
4	Urinary Tract Infections (Urinary Tract Infection) 08/2015 - 12/2005
4	Cystitis 08/2015 - 10/2002
4	Peritonitis 03/2012 - 01/2002
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 08/2012
3	Healthcare-Associated Pneumonia 01/2021 - 01/2017
3	Ventilator-Associated Pneumonia 01/2021 - 09/2014
3	Human Influenza (Influenza) 01/2021 - 02/2015
3	Communicable Diseases (Infectious Diseases) 04/2020 - 01/2004
3	Critical Illness (Critically Ill) 01/2016 - 03/2009
3	Bacterial Infections (Bacterial Infection) 08/2015 - 01/2002
3	Prostatitis 01/2005 - 01/2002
2	Encephalitis (Encephalitis, Rasmussen) 10/2021 - 04/2020
2	Meningitis 10/2021 - 04/2020
2	Central Nervous System Infections (Central Nervous System Infection) 10/2021 - 04/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2019 - 05/2016
2	Inflammation (Inflammations) 11/2019 - 01/2014
2	Impetigo (Impetigo Contagiosa) 01/2019 - 01/2018
2	Pneumococcal Infections 01/2018 - 05/2016
2	Body Weight (Weight, Body) 01/2017 - 05/2013
2	Septic Shock (Toxic Shock Syndrome) 01/2017 - 04/2014
2	Melioidosis 04/2015 - 01/2015
1	Lung Injury 01/2018
1	Soft Tissue Infections 01/2018

Drug/Important Bio-Agent (IBA)

27	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2002
8	Carbapenems (Carbapenem Antibiotics)IBA 09/2020 - 02/2009
8	Anti-Infective Agents (Microbicides)IBA 04/2020 - 01/2004
8	QuinolonesIBA 01/2019 - 01/2002
6	Colistin (Coly-Mycin)FDA Link 03/2020 - 02/2009
6	Virulence Factors (Pathogenicity Factors)IBA 08/2015 - 12/2002
5	FluoroquinolonesIBA 08/2015 - 07/2003
4	Pharmaceutical PreparationsIBA 01/2021 - 11/2012
4	Biomarkers (Surrogate Marker)IBA 11/2019 - 06/2014
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2014
4	Norfloxacin FDA Link 03/2012 - 01/2002
3	ozenoxacinIBA 01/2019 - 03/2014
3	Third Generation CephalosporinsIBA 01/2019 - 01/2012
3	VaccinesIBA 05/2016 - 01/2015
2	Antiviral Agents (Antivirals)IBA 06/2022 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2022 - 08/2015
2	C-Reactive ProteinIBA 01/2022 - 11/2019
2	tazobactam drug combination ceftolozaneIBA 01/2021 - 01/2021
2	ProcalcitoninIBA 11/2019 - 01/2017
2	EndotoxinsIBA 01/2017 - 04/2014
2	Lipopolysaccharide ReceptorsIBA 02/2016 - 01/2014
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2016 - 01/2002
2	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 04/2006
2	Nucleic AcidsIBA 02/2015 - 08/2009
2	EnzymesIBA 10/2014 - 10/2009
2	AlbuminsIBA 09/2014 - 01/2004
2	Cephalosporins (Cephalosporin Antibiotics)IBA 08/2014 - 03/2009
2	Imipenem FDA Link 07/2014 - 04/2009
2	Vancomycin FDA LinkGeneric 08/2012 - 07/2012
2	Linezolid (Zyvox)FDA Link 08/2012 - 07/2012
2	Nalidixic Acid FDA Link 03/2010 - 10/2002
2	beta-LactamsIBA 05/2006 - 06/2003
2	GlycopeptidesIBA 06/2003 - 04/2003
2	Hemolysin Proteins (Hemolysins)IBA 12/2002 - 10/2002
2	aerobactinIBA 12/2002 - 10/2002
1	CefiderocolIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	ClinitestIBA 01/2022
1	AntigensIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	remdesivirIBA 11/2021
1	avibactamIBA 01/2021
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	Meropenem (Merrem)FDA LinkGeneric 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2019
1	CeramidesIBA 11/2019
1	LipidsIBA 11/2019
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 11/2019
1	SphingomyelinsIBA 11/2019
1	AcidsIBA 11/2019
1	LactamsIBA 01/2019
1	CephamycinsIBA 01/2019
1	Lipocalin-2IBA 01/2019
1	N-(3-oxododecanoyl)homoserine lactoneIBA 01/2018
1	Lysergic Acid Diethylamide (LSD)IBA 01/2018
1	Loperamide (Imodium)FDA LinkGeneric 04/2017
1	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 04/2017

Therapy/Procedure

22	Therapeutics 06/2022 - 01/2002
3	Critical Care (Surgical Intensive Care) 07/2022 - 12/2015
2	Length of Stay 01/2021 - 01/2016
2	Catheters 01/2016 - 03/2011
2	Parenteral Nutrition 05/2015 - 04/2006
2	Prostheses and Implants (Prosthesis) 10/2011 - 01/2008
1	Personal Protective Equipment 12/2021
1	Aftercare (After-Treatment) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Antibiotic Prophylaxis 04/2017